Filtered By:
Cancer: Carcinoma
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 251 results found since Jan 2013.
Cerebellar Stroke and Leptomeningeal Carcinomatosis Following Cement Embolization of the Vertebral Artery During Cervical Vertebroplasty
Source: Journal of Vascular and Interventional Radiology : JVIR - September 28, 2021 Category: Radiology Authors: Fabrice Bing, Jad Dandache, Luce Mettey, Wilfried Vadot, Laetitia Stefani Tags: Letter to the Editor Source Type: research
Cerebellar Stroke and Leptomeningeal Carcinomatosis following Cement Leakage into the Vertebral Artery during Cervical Vertebroplasty
This report describes an unusual vertebral artery cement embolization during C3 transpedicular vertebroplasty performed under computed tomography (CT) guidance and fluoroscopy. The Institutional Review Board approved this case report, and the patient ’s consent for publication was obtained. A 54-year-old woman with an invasive lobular breast carcinoma suffered from cervical pain. A CT scan showed spinal osteolytic lesions. A thoracic vertebral biopsy confirmed the diagnosis of breast cancer metastasis.
Source: Journal of Vascular and Interventional Radiology : JVIR - September 28, 2021 Category: Radiology Authors: Fabrice Bing, Jad Dandache, Luce Mettey, Wilfried Vadot, Laetitia Stefani Tags: Letter to the Editor Source Type: research
Elevated CA125 is Related to Stroke Due to Cancer- Associated Hypercoagulation
It is well-known that cancer patients commonly have ischemic stroke and the incidence is getting increased with the development of cancer therapy prolonging survival.1 Ischemic stroke in cancer patients is caused by various etiologies. Cancer-associated hypercoagulation is one of the major important pathophysiological mechanisms of stroke in cancer patients.2,3 This hypercoagulation is mediated by multiple mechanisms associated with tissue factor, mucin, and cysteine proteinase. Carcinomatous mucins are considered to trigger thrombogenicity by interacting with P and L selectins and inducing the formation of platelet-rich microthrombi.
Source: Journal of Stroke and Cerebrovascular Diseases - September 27, 2021 Category: Neurology Authors: Keiko Maezono-Kandori, Tomoyuki Ohara, Jun Fujinami, Naoki Makita, Eijirou Tanaka, Toshiki Mizuno Source Type: research
Striving to Deliver Better Outcomes: Janssen to Showcase Commitment to Advancing Science for Genitourinary Cancers at AUA 2021
August 31, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today multiple company-sponsored presentations in prostate and bladder cancers will be highlighted at the virtual 2021 American Urological Association Annual Meeting (AUA 2021), September 10-13. “Janssen maintains a strong commitment to advancing innovation and new therapeutic options for patients with genitourinary malignancies. As the treatment of genitourinary cancers becomes more complex, we continue to work with urologists and their teams to improve outcomes for patients across the continuum of disease,” sai...
Source: Johnson and Johnson - August 31, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news
E-100 Endovascular management of refractory nasopharyngeal and oropharyngeal bleeding: Case series
ConclusionEndovascular treatment of oronasal bleeding is safe and effective at achieving hemostasis but associated with an 18.2% rebleeding rate.Disclosures H. Hoffman: None. G. Gould: None.
Source: Journal of NeuroInterventional Surgery - July 26, 2021 Category: Neurosurgery Authors: Hoffman, H., Gould, G. Tags: Electronic poster abstracts Source Type: research
Neurological Complications After Electrochemotherapy Treatment in the Head and Neck Area
CONCLUSION: ECT in the head and neck can potentially cause severe neurological complications. Ultrasound is recommended for ECT treatment in the neck.PMID:34230147 | DOI:10.21873/anticanres.15139
Source: Cell Research - July 7, 2021 Category: Cytology Authors: Fredrik Landstr öm Stefan Kristiansson Peter Appelros Source Type: research
Perioperative outcomes of goal-directed versus conventional fluid therapy in radical cystectomy with enhanced recovery protocol
ConclusionStroke volume variation guided goal-directed fluid therapy is safe in radical cystectomy without compromising the renal function. It is associated with less intra- and perioperative fluid infusion; however, no association with hospital stay, 90-day complication or readmission rates were noted.
Source: International Urology and Nephrology - June 4, 2021 Category: Urology & Nephrology Source Type: research
Late vascular complications after cranial radiotherapy: A report of two illustrative cases
We present two cases of late neurological complications after CRT and briefly discuss its diagnosis and their shared pathophysiological aspects. The first case is a patient with cognitive impairment associated to mineralizing microangiopathy ten years after CRT for nasopharyngeal carcinoma and the second one is a woman with Stroke-like Migraine Attacks after Radiation Therapy (SMART) syndrome two years after CRT for anaplastic meningioma. Nowadays, higher survival rates might cause an increase in appearance of late neurological complications after CTR. These reported cases show that late complications can mimic a wide vari...
Source: Cancer Radiotherapie - April 27, 2021 Category: Cancer & Oncology Authors: J Madera A S ánchez-Soblechero P Navarrete Solano U Corro Verde E Marco de Lucas M Pacheco Baldor P J Prada J Pascual Source Type: research
Janssen Announces U.S. FDA Approval of PONVORY ™ (ponesimod), an Oral Treatment for Adults with Relapsing Multiple Sclerosis Proven Superior to Aubagio® (teriflunomide) in Reducing Annual Relapses and Brain Lesions
TITUSVILLE, N.J. – (March 19, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.1,2,3 PONVORY™ offers MS patients superior efficacy in reducing annualized relapse rates compared to an established oral therapy and a proven safety profile backed by ove...
Source: Johnson and Johnson - March 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Tumor Cells Detected in Retrieved Thrombus: A Case of Cancer-associated Stroke
Intern Med. 2021 Mar 8. doi: 10.2169/internalmedicine.6201-20. Online ahead of print.ABSTRACTA 51-year-old man with a history of renal cell carcinoma presented with sudden aphasia, right hemiparesis, and dysesthesia. MRA showed left middle cerebral artery occlusion, and he was diagnosed with acute ischemic stroke and treated with intravenous recombinant tissue plasminogen activator and endovascular thrombectomy. The pathological diagnosis of the retrieved thrombus was consistent with the already-known pathological findings of the primary renal cell carcinoma. Therefore, a diagnosis of cerebral embolism caused by tumor cell...
Source: Internal Medicine - March 8, 2021 Category: Internal Medicine Authors: Kaoru Nakanishi Hiroyuki Kawano Yuki Yamagishi Hiroshi Kamma Yoshiaki Shiokawa Teruyuki Hirano Source Type: research
